Humasis Co. Ltd. (KOSDAQ:205470)
South Korea · Delayed Price · Currency is KRW 1,141.00
-11.00 (-0.95%)
Dec 10, 2025, 3:30 PM KST
Humasis Market Cap
Humasis has a market cap or net worth of 130.35 billion as of December 10, 2025. Its market cap has decreased by -28.80% in one year.
Market Cap
130.35B
Enterprise Value
-23.32B
Revenue
35.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,141.00
Market Cap Chart
Since September 27, 2017, Humasis's market cap has increased from 10.76B to 130.35B, an increase of 1,111.10%. That is a compound annual growth rate of 35.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 130.35B | -29.63% |
| Dec 30, 2024 | 185.23B | -22.80% |
| Dec 28, 2023 | 239.92B | -47.44% |
| Dec 29, 2022 | 456.45B | -20.07% |
| Dec 30, 2021 | 571.04B | 75.79% |
| Dec 30, 2020 | 324.84B | 729.52% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.41T |
| Celltrion | 40.94T |
| ALTEOGEN | 24.49T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.44T |
| Yuhan | 8.66T |
| LigaChem Biosciences | 6.75T |
| HLB Co., Ltd. | 6.53T |